Telomerase activity in clinically normal dogs and dogs with malignant lymphoma

American Journal of Veterinary Research

Volumn 62, Issue 9, 2001, Pages 1442-1446

  Carioto, Lisa M ^a,b   Kruth, Stephen A ^a   Betts, Dean H ^a   King, W Allan ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b Centre Veterinaire D M V   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

TELOMERASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; BLOOD; DOG; DOG DISEASE; ENZYMOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER; LYMPH NODE; LYMPHOMA; MALE; METABOLISM; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY;

ANIMALS; BIOPSY, NEEDLE; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER; LYMPH NODES; LYMPHOMA; MALE; STATISTICS, NONPARAMETRIC; TELOMERASE;

EID: 0035460287     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.1442     Document Type: Article

References (26)

1. Shay JW, Brasiskyte D, Ouelette M. Analysis of telomerase and telomeres. Methods Mol Gen 1994;5:263-280.
2. Shay JW. Aging and cancer: are telomeres and telomerase the connection? Mol Med Today 1995;1:378-384.
3. Greider CW. Telomerase and telomere-length regulation: Lessons from small eukaryotes to mammals. Cold Spring Harb Symp Quant Biol 1993;58:719-723.
4. Zakian VA. Telomeres. Beginning to understand the end. Science 1995;270:1601-1607.
5. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-894.
6. Bacchetti S, Counter CM. Telomeres and telomerase in human cancer (review). Int J Oncol 1995;7:423-432.
7. Shay JW, Werbin H, Wright WE. You haven't heard the end of it: telomere loss may link human aging with cancer. Can J Aging 1995;14:511-524.
8. Shay JW. Telomerase in human development and cancer. J Cell Physiol 1997;173:266-270.
9. Biller B, Kitchell B, Casey CD. Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs. Am J Vet Res 1998;59:1526-1529.
10. Spangler E, Rogers KS, Thomas JS, et al. Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and benign origin. J Vet Intern Med 2000;14:146-150.
11. Ogilvie GK, Moore AS. Managing the veterinary cancer patient. A practice manual. 1st ed. Trenton, NJ: Veterinary Learning Systems Co, 1995;228-259.
12. MacEwen EG, Young KM. Canine lymphoma and lymphoid leukemias. In: Withrow SJ, MacEwen GE, eds. Small animal clinical oncology. 2nd ed. Philadelphia: WB Saunders Co, 1996;451-479.
13. Vonderhaar MA, Morrison WB. Lymphosarcoma. In: Morrison WB, ed. Cancer in dogs and cats. Medical and surgical management. 1st ed. Baltimore: The Williams & Wilkins Co, 1998;667-695.
14. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2014.
15. Carter RF, Valli VEO, Lumsden JH. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation. Can J Vet Res 1986;50:154-164.
16. SAS User's Guide: version 5 edition. Cary, NC: SAS Institute Inc, 1985.
17. Norrback KF, Roos G. Telomeres and telomerase in normal and malignant hematopoietic cells. Eur J Cancer 1997;33:774-780.
18. Nilsson P, Mehle C, Remes K, et al. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994;9: 3043-3048.
19. Miura N, Horikawa I, Nishimoto A, et al. Progressive teloere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 1997;93:56-62.
20. Tahara H, Nakanishi T, Kitamoto M. Telomerase activity in human liver tissues: correlation between chronic liver disease and hepatocellular carcinoma. Cancer Res 1995;55:2734-2736.
21. Nouso K, Urabe Y, Higashi T. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996;76:232-236.
22. Nakashio R, Kitamoto M, Tahara H, et al. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 1997;74:141-147.
23. Brousset P, Saati TA, Chaouche N, et al. Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. Blood 1997;89:26-31.
24. Yashima K, Piatyszek M, Saboorian HM, et al. Telomerase activity as in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997;50:110-117.
25. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
26. Norrback KF, Dahlenborg K, Carlsson R, et al. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996;88:222-229.